Institut Claudius Regaud
5Patents
5Active
5Granted
43Portfolio score
Filing activity: May 18, 2011 → Dec 4, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10544210B2 | Anti-Rho GTPase conformational single domain antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8865408B2 | Signature for the diagnosis of cancer aggressiveness and genetic instability | Chemistry; Metallurgy | 0 | Active |
| US11319381B2 | Anti-rho GTPase conformational single domain antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10144772B2 | Method for treating melanoma | Physics | 0 | Active |
| US11186634B2 | Antibodies targeting tumor associated macrophages and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.